View in EDS

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.

Saved in:
Bibliographic Details
Title: Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.
Authors: Nicolay JP; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; Section of Clinical and Experimental Dermatology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Melchers S; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; Section of Clinical and Experimental Dermatology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Albrecht JD; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; Section of Clinical and Experimental Dermatology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Assaf C; Department of Dermatology and Venereology, Helios Klinikum Krefeld, Krefeld, Germany.; Institute for Molecular Medicine, Medical School Hamburg, Hamburg, Germany., Dippel E; Department of Dermatology, Ludwigshafen Medical Center, Ludwigshafen, Germany., Stadler R; University Clinic for Dermatology, Johannes Wesling Medical Center, Minden, Germany., Wehkamp U; Department of Dermatology, Campus Kiel, University Hospital Schleswig-Holstein, Kiel, Germany., Wobser M; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Zhao J; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany., Burghaus I; Clinical Study Coordination Center, University of Heidelberg, Heidelberg, Germany., Schneider S; Institute for Clinical Chemistry, University Medical Center Mannheim, Mannheim, Germany., Gülow K; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious diseases, University Hospital Regensburg, Regensburg, Germany., Goerdt S; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany., Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany., Utikal JS; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany., Krammer PH; Department of Immunogenetics D030, German Cancer Research Center, Heidelberg, Germany.
Source: Blood [Blood] 2023 Aug 31; Vol. 142 (9), pp. 794-805.
Publication Type: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37217183
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nicolay+JP%22">Nicolay JP</searchLink>; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; Section of Clinical and Experimental Dermatology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Melchers+S%22">Melchers S</searchLink>; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; Section of Clinical and Experimental Dermatology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Albrecht+JD%22">Albrecht JD</searchLink>; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; Section of Clinical and Experimental Dermatology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Assaf+C%22">Assaf C</searchLink>; Department of Dermatology and Venereology, Helios Klinikum Krefeld, Krefeld, Germany.; Institute for Molecular Medicine, Medical School Hamburg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Dippel+E%22">Dippel E</searchLink>; Department of Dermatology, Ludwigshafen Medical Center, Ludwigshafen, Germany.<br /><searchLink fieldCode="AU" term="%22Stadler+R%22">Stadler R</searchLink>; University Clinic for Dermatology, Johannes Wesling Medical Center, Minden, Germany.<br /><searchLink fieldCode="AU" term="%22Wehkamp+U%22">Wehkamp U</searchLink>; Department of Dermatology, Campus Kiel, University Hospital Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Wobser+M%22">Wobser M</searchLink>; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Burghaus+I%22">Burghaus I</searchLink>; Clinical Study Coordination Center, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schneider+S%22">Schneider S</searchLink>; Institute for Clinical Chemistry, University Medical Center Mannheim, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Gülow+K%22">Gülow K</searchLink>; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious diseases, University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Goerdt+S%22">Goerdt S</searchLink>; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Schürch+CM%22">Schürch CM</searchLink>; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Utikal+JS%22">Utikal JS</searchLink>; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim/ University of Heidelberg, Mannheim, Germany.; Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Krammer+PH%22">Krammer PH</searchLink>; Department of Immunogenetics D030, German Cancer Research Center, Heidelberg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2023 Aug 31; Vol. 142 (9), pp. 794-805.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37217183
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2022018669
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 794
    Titles:
      – TitleFull: Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nicolay JP
      – PersonEntity:
          Name:
            NameFull: Melchers S
      – PersonEntity:
          Name:
            NameFull: Albrecht JD
      – PersonEntity:
          Name:
            NameFull: Assaf C
      – PersonEntity:
          Name:
            NameFull: Dippel E
      – PersonEntity:
          Name:
            NameFull: Stadler R
      – PersonEntity:
          Name:
            NameFull: Wehkamp U
      – PersonEntity:
          Name:
            NameFull: Wobser M
      – PersonEntity:
          Name:
            NameFull: Zhao J
      – PersonEntity:
          Name:
            NameFull: Burghaus I
      – PersonEntity:
          Name:
            NameFull: Schneider S
      – PersonEntity:
          Name:
            NameFull: Gülow K
      – PersonEntity:
          Name:
            NameFull: Goerdt S
      – PersonEntity:
          Name:
            NameFull: Schürch CM
      – PersonEntity:
          Name:
            NameFull: Utikal JS
      – PersonEntity:
          Name:
            NameFull: Krammer PH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 08
              Text: 2023 Aug 31
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 142
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1